Skip to main content
. Author manuscript; available in PMC: 2017 Feb 6.
Published in final edited form as: Biochim Biophys Acta. 2015 Jan 31;1851(5):577–587. doi: 10.1016/j.bbalip.2015.01.008

Fig. 3.

Fig. 3

Induction of ACSL4 protein expression in human primary hepatocytes by PPAR agonists. Human primary hepatocytes of two different donors (Hu8123, Hu8150) were treated with L165041 (20 µM) orWY14643 (50 µM) for 24 h. Triplicate wells were used in each condition. ACSL4 protein abundance was analyzed by Western blotting and q-PCR was performed to measure relative mRNA levels of indicated genes. * p < 0.05, ** p < 0.01 and *** p < 0.001 compared to the DMSO control.